News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Horizon Discovery Ltd. Sign Cancer Metabolomics Service Agreement with Global Pharma GlaxoSmithKline
October 13, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Horizon Discovery -- Horizon Discovery (Horizon) today announced it has signed a commercial service agreement with Global Pharmaceutical company; GlaxoSmithKline relating to its X-MAN technology.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Legal
BMS, Sanofi Settle Plavix Suit With Hawaii for $700M
May 12, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Insitro Cuts 22% of Workforce, Extending Runway Into 2027
May 9, 2025
·
2 min read
·
Angela Gabriel
Layoffs
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM
May 9, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
May 9, 2025
·
2 min read
·
Tristan Manalac